BMY vs UPBD · P/E 17, rev $24.46B vs P/E 12, rev $2.38B
Bristol-Myers Squibb Company (BMY) versus Upbound Group Inc. (UPBD) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Upbound Group Inc. (UPBD) is a software - application company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported UPBD revenue for 2026-06-30 was $2.38B. Net income was $57.4M. Revenue was up 95.4% from 2026-03-31 to 2026-06-30. UPBD currently screens at market cap $1.02B and trailing P/E 12.1.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. UPBD currently screens at market cap $1.02B and trailing P/E 12.1.
Not investment advice. Open the BMY and UPBD stock pages for the full models.
Not investment advice.